Danish biotechnology and its long tradition of close collaboration between research institutions, academic and commercial researchers are at the center of focus in the latest issue of the acclaimed scientific publication European Biopharmaceutical Review (EBR).

The article is written by Invest in Denmark's Regional Project Manager Rasmus Beedholm-Ebsen, who holds a PhD in Medicine from Aarhus University and an MSc in Molecular Biology.